4D Molecular Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $58.2M
Liabilities Breakdown FY2019
Total Liabilities: $28.2M
Asset Breakdown
Total Assets: $58.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $49.7M | 85.3% |
| Accounts Receivable | $978.0K | 1.7% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.0M | 8.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.6M | 4.4% |
Liabilities Breakdown
Total Liabilities: $28.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 6.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $26.5M | 93.8% |